Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 1-Week, Multi-Center, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Parallel Trial Comparing Lumiracoxib (400 mg Once Daily) in Patients With Acute Flares of Gout, Using Indomethacin (50 mg Three Times a Day)

NCT00170781 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00170781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00170781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 1-Week, Multi-Center, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Parallel Trial Comparing Lumiracoxib (400 mg Once Daily) in Patients With Acute Flares of Gout, Using Indomethacin (50 mg Three Times a Day)
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2005
Completion date
Not reported
Enrollment
234
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute gouty arthritis